Insider Shareholders with Direct Ownership of Flexion Therapeutics Inc (FLXN)
This section provides a comprehensive overview of the insiders with direct ownership of Flexion Therapeutics Inc (FLXN). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Flexion Therapeutics Inc Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
David Arkowitz
Chief Financial Officer |
71,900 | 8,302 | 220,719 $2.02 Million | 3 |
May 10, 2021
Reduced 1.0%
|
|
Scott Kelley
Chief Medical Officer |
30,000 | 6,829 | 143,549 $1.31 Million | 2 |
Mar 01, 2021
Added 17.29%
|
|
Heath Lukatch
Director |
4,500 | 9,000 | 0 $0 | 2 |
Nov 19, 2021
Reduced 100.0%
|
|
Frederick W Driscoll
Chief Financial Officer |
28,000 | 30,680 | 0 $0 | 2 |
Nov 19, 2021
Reduced 100.0%
|
|
Mark S. Levine
General Counsel |
30,000 | 144,260 | 0 $0 | 4 |
Nov 19, 2021
Reduced 100.0%
|
|
Kerry Wentworth
Chief Regulatory Officer |
30,539 | 151,616 | 0 $0 | 5 |
Nov 19, 2021
Reduced 100.0%
|
|
Scott A Canute
Director |
4,500 | 9,000 | 0 $0 | 2 |
Nov 19, 2021
Reduced 100.0%
|
|
Adam Muzikant
Chief Business Officer |
32,081 | 109,541 | 0 $0 | 5 |
Nov 19, 2021
Reduced 100.0%
|
|
Christina Willwerth
Chief Strategy Officer |
30,000 | 151,788 | 0 $0 | 4 |
Nov 19, 2021
Reduced 100.0%
|
|
Michael D. Clayman
President and CEO |
227,300 | 387,827 | 0 $0 | 10 |
Nov 19, 2021
Reduced 100.0%
|
|
Samuel D Colella
Director |
4,500 | 9,000 | 0 $0 | 2 |
Nov 19, 2021
Reduced 100.0%
|
|
Melissa Layman
Chief Commercial Officer |
50,100 | 111,100 | 0 $0 | 5 |
Nov 19, 2021
Reduced 100.0%
|
|
Patrick J Mahaffy
Director |
4,500 | 39,824 | 0 $0 | 2 |
Nov 19, 2021
Reduced 100.0%
|
|
C Ann Merrifield
Director |
4,500 | 19,000 | 0 $0 | 2 |
Nov 19, 2021
Reduced 100.0%
|
|
Elizabeth Kwo
Director |
4,500 | 4,500 | 0 $0 | 2 |
Nov 19, 2021
Reduced 100.0%
|
|
Mark Stejbach
Director |
4,500 | 12,631 | 0 $0 | 2 |
Nov 19, 2021
Reduced 100.0%
|
|
Alan Milinazzo
Director |
4,500 | 27,450 | 0 $0 | 2 |
Nov 19, 2021
Reduced 100.0%
|
|
William T. Andrews
Chief Medical Officer |
34,250 | 34,250 | 0 $0 | 2 |
Nov 19, 2021
Reduced 100.0%
|